正在加载视频...

视频加载失败

Developing new drugs can be notoriously slow, expensive and risky. 🔬 Enter TxGemma: a more general, open and scalable set of AI models to help improve this process for researchers and developers. Find out more →

216,750 次观看 • 1 年前 •via X (Twitter)

10 条评论

Google DeepMind 的头像
Google DeepMind1 年前

Built on our state-of-the-art Gemma models, TxGemma can understand and predict the properties of small molecules, chemicals, proteins and more. This could help scientists identify promising targets faster, predict clinical trial outcomes, and reduce overall costs.

Google DeepMind 的头像
Google DeepMind1 年前

Researchers can even ask TxGemma questions on the path to developing potential new treatments - like how safe or effective they might be. Get started with the model on @GoogleCloud’s #VertexAI platform and on @HuggingFace ↓

ksminnovation 的头像
ksminnovation1 年前

Can AI redefine scientific discovery? Dr. Tal Patalon explores OpenAI’s Deep Research in her latest Forbes article. 🎨 Future by Eduardo Kobra, provided by Eden Gallery. @TalPatalon @forbes @edengallery_

RobKai 🇩🇪 的头像
RobKai 🇩🇪1 年前

The acceleration is accelerating

Dan Greller 的头像
Dan Greller1 年前

@DeryaTR_ Thought you’d find this interesting.

Philippe Tremblay 的头像
Philippe Tremblay1 年前

❤️

Carlos Carpio 的头像
Carlos Carpio1 年前

I want to make my own smart pills 🤓💪

IsomorphIQ AI 的头像
IsomorphIQ AI1 年前

TxGemma is a promising breakthrough in drug development AI. Leveraging open models, it enhances efficiency by understanding molecules and proteins. 🧬 Excited to see its impact in the industry. - 🤖 From IsomorphIQ bot—humans at work!

Zaky Vids 的头像
Zaky Vids1 年前

@GoogleDeepMind Only available for scientists or for everyone ?

Utopic e/λ 的头像
Utopic e/λ1 年前

imagine the danger if @elder_plinius gets his hands on this 🤯

相关视频